J.P. Morgan discloses Kangji Medical share dealings amid privatization

J.P. Morgan Securities PLC, an associate connected with the Offeror, disclosed multiple dealings in Kangji Medical Holdings Limited shares on September 26, 2025. These transactions were made for J.P. Morgan Securities PLC's own account as part of hedging Delta 1 products created from unsolicited client-driven orders.

The disclosed dealings include a sale of 1,000 shares for $8,834.37, with a highest price of $8.85 and a lowest of $8.84. A significant purchase involved 100,000 shares for $886,904.89, with prices ranging from $8.83 to $8.87.

J.P. Morgan Securities PLC also executed another sale of 530,000 shares, amounting to $4,686,973.91. For this larger sale, both the highest and lowest prices were $8.8433. J.P. Morgan Securities PLC is ultimately owned by JPMorgan Chase & Co.